As our understanding of the mechanisms of cancer treatment has increased, a growing
number of studies demonstrate pathways through which DNA damage repair (DDR) affects …

Cancer immunotherapy has revolutionized the oncology field, but many patients still do not
respond to current immunotherapy approaches. One of the main challenges in broadening …

We examined the protective effect of the apigeninidin (API)-enriched fraction from Sorghum
bicolor sheaths extracts (SBE-05, SBE-06, and SBE-07) against aflatoxin B1 (AFB1)-induced …

Many chemicals, including many endocrine disruptors (EDCs) are known to leach out from
various plastic consumer products and waste, and are widespread in the environment …

This research investigates the potentials of prodigiosin (PG) derived from bacteria and its
formulations against triple-negative breast (TNB), lung, and colon cancer cells. The PG was …

Following SARS-CoV-2 infection in humans, there is upregulation of proinflammatory
molecules S100 calcium binding protein B (S100B), high-mobility group box-1 (HMGB1) …

Advances in understanding the genetic basis of cancer have driven alternative treatment
approaches. Recent findings have demonstrated the potential of bacteria and it's …

Low‐grade cervical intraepithelial neoplasia (CIN1) is an early stage of cervical cancer
development. Previously, we reported that exposure to polycyclic aromatic hydrocarbons …

Hepatocellular carcinoma (HCC) is a significant health problem for human life; therefore,
new therapeutic approaches are essential. In vitrostudies have shown that the extract …

Cancer has traditionally been viewed as a genetic disorder resulting from the accumulation
of gene mutations, chromosomal rearrangements, and aneuploidies in somatic cells …